Autoantibodies Signal Reduced Cancer Risk in Dermatomyositis
In patients with dermatomyositis positive for anti-TIF1-γ autoantibodies, the presence of anti-CCAR1 autoantibodies indicate normal rather than elevated cancer risk.
Stanford University United States National Institutes Of Health David Fiorentino Manabu Fujimoto Christophera Mecoli
Source: medscape.com